You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 132 No. 10, October 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  OBSERVATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Angiokeratoma Corporis Diffusum Associated With β-Mannosidase Deficiency

Mercedes Rodríguez-Serna, PhD; Rafael Botella-Estrada, MD; Amparo Chabás, PhD; María-José Coll, PhD; Vicente Oliver, PhD; María-Isabel Febrer, PhD; Adolfo Aliaga, PhD

Arch Dermatol. 1996;132(10):1219-1222.


Abstract

Background
Angiokeratoma corporis diffusum (ACD) was at one time thought to be synonymous with Anderson-Fabry disease. However, it is well known that widespread angiokeratomas may also be found in other lysosomal enzyme disorders, as well as in patients with normal enzyme activities. β-Mannosidase deficiency was first described in humans in 1986; since then, only 11 cases of β-mannosidase deficiency, which occurred in 8 families, have been reported. Although the clinical manofestations are varied, mental retardation and neurologic disorders are present in practically all patients.

Observations
We describe a 22-year-old woman who, since the age of 12 years, presented with progressive ACD affecting the lower limbs and the buttocks. Enzymatic studies revealed β-mannosidase deficiency in cultured fibroblasts and in samples of serum and leukocytes. The patient's parents in turn exhibited intermediate enzyme levels, thus confirming the recessive autosomal hereditary nature of the disease. With the exception of an introverted character, the patient demonstrated no other anomalies.

Conclusions
This is the first case of β-mannosidase deficiency diagnosed as a result of purely dermatologic findings, in the form of ACD. β-Mannosidase deficiency should therefore be included when screening for enzyme abnormalities in patients with ACD, even in the absence of neurologic disorders or mental retardation.

Arch Dermatol. 1996;132:1219-1222



Author Affiliations

From the Department of Dermatology, University General Hospital, Valencia (Drs Rodríguez-Serna, Botella-Estrada, Oliver, Febrer, and Aliaga), and the Institut de Bioquímica Clínica, Corporació Sanitaria, Cerdanyola (Drs Chabás and Coll), Spain.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Angiokeratoma corporis diffusum in a patient with no recognizable enzyme abnormalities.
Kelly and Kelly
Arch Dermatol 2006;142:615-618.
ABSTRACT | FULL TEXT  

{beta}-Mannosidosis mice: a model for the human lysosomal storage disease
Zhu et al.
Hum Mol Genet 2006;15:493-500.
ABSTRACT | FULL TEXT  

Atypical Gilles de la Tourette Syndrome With {beta}-Mannosidase Deficiency
Sedel et al.
Arch Neurol 2006;63:129-131.
ABSTRACT | FULL TEXT  

Fabry Disease: A Study of 6 Hemizygous Men and 5 Heterozygous Women With Emphasis on Dermatologic Manifestations
Larralde et al.
Arch Dermatol 2004;140:1440-1446.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.